Allstate Corporation’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.29M Buy
107,175
+10,853
+11% +$1.04M 0.1% 119
2025
Q4
$9.25M Buy
96,322
+49,708
+107% +$4.83M 0.13% 106
2025
Q3
$4.44M Buy
46,614
+44,085
+1,743% +$4.05M 0.1% 112
2025
Q2
$220K Sell
2,529
-38,930
-94% -$3.3M 0.02% 163
2025
Q1
$3.73M Buy
41,459
+3,219
+8% +$288K 0.11% 116
2024
Q4
$3.05M Buy
+38,240
New +$3.31M 0.09% 126
2024
Q3
Sell
-4,195
Closed -$330K 184
2024
Q2
$330K Sell
4,195
-32
-0.8% -$2.62K 0.03% 157
2024
Q1
$368K Sell
4,227
-323
-7% -$27.6K 0.03% 146
2023
Q4
$375K Buy
4,550
+707
+18% +$53.9K 0.03% 134
2023
Q3
$301K Hold
3,843
0.02% 155
2023
Q2
$339K Buy
3,843
+545
+17% +$46.9K 0.02% 149
2023
Q1
$266K Sell
3,298
-53,026
-94% -$4.32M 0.02% 160
2022
Q4
$4.38M Buy
56,324
+195
+0.3% +$15.8K 0.13% 110
2022
Q3
$4.53M Buy
56,129
+8,720
+18% +$784K 0.13% 93
2022
Q2
$4.25M Sell
47,409
-23,283
-33% -$2.36M 0.13% 103
2022
Q1
$7.84M Sell
70,692
-66,315
-48% -$7.01M 0.21% 64
2021
Q4
$14.2M Buy
137,007
+109,606
+400% +$12.7M 0.27% 59
2021
Q3
$3.44M Sell
27,401
-2,888
-10% -$374K 0.14% 66
2021
Q2
$3.76M Sell
30,289
-2,565
-8% -$322K 0.13% 66
2021
Q1
$3.88M Buy
32,854
+2,680
+9% +$314K 0.12% 70
2020
Q4
$3.54M Sell
30,174
-2,540
-8% -$280K 0.11% 64
2020
Q3
$3.4M Sell
32,714
-2,434
-7% -$244K 0.11% 61
2020
Q2
$3.22M Sell
35,148
-3,491
-9% -$335K 0.11% 68
2020
Q1
$3.48M Sell
38,639
-57,177
-60% -$6.08M 0.14% 58
2019
Q4
$10.9M Sell
95,816
-9,463
-9% -$1.04M 0.2% 59
2019
Q3
$11.4M Buy
105,279
+11,199
+12% +$1.17M 0.2% 52
2019
Q2
$9.16M Sell
94,080
-34,678
-27% -$3.17M 0.16% 66
2019
Q1
$11.7M Buy
128,758
+57
+0% +$5.1K 0.32% 48
2018
Q4
$11.7M Buy
+128,701
New +$12M 0.38% 42
2017
Q3
Sell
-5,671
Closed -$503K 168
2017
Q2
$503K Sell
5,671
-35,326
-86% -$2.98M 0.03% 291
2017
Q1
$3.3M Buy
40,997
+16,952
+71% +$1.32M 0.2% 75
2016
Q4
$1.71M Sell
24,045
-40,680
-63% -$3.2M 0.1% 194
2016
Q3
$5.59M Sell
64,725
-18,753
-22% -$1.63M 0.39% 56
2016
Q2
$7.24M Sell
83,478
-10,819
-11% -$875K 0.47% 49
2016
Q1
$7.07M Buy
94,297
+68,998
+273% +$5.2M 0.61% 65
2015
Q4
$1.95M Sell
25,299
-14,425
-36% -$1.09M 0.19% 134
2015
Q3
$2.66M Buy
39,724
+10,694
+37% +$788K 0.27% 108
2015
Q2
$2.15M Sell
29,030
-39,097
-57% -$2.99M 0.19% 134
2015
Q1
$5.31M Buy
68,127
+8,924
+15% +$676K 0.44% 56
2014
Q4
$4.27M Sell
59,203
-59,630
-50% -$4.14M 0.33% 103
2014
Q3
$7.36M Sell
118,833
-95,100
-44% -$6.05M 0.34% 88
2014
Q2
$13.6M Buy
213,933
+62,840
+42% +$3.82M 0.37% 83
2014
Q1
$9.3M Buy
151,093
+36,791
+32% +$2.14M 0.3% 94
2013
Q4
$6.56M Hold
114,302
0.24% 110
2013
Q3
$6.09M Hold
114,302
0.24% 95
2013
Q2
$5.88M Buy
+114,302
New +$5.65M 0.27% 84

Other funds holding MDT

Allstate Corporation's MDT Position: Q1 2026 in Review

Allstate Corporation increased its Medtronic (MDT) stake by 11% in Q1 2026, buying an estimated $1.04M and bringing the position to 107,175 shares worth $9.29M. The position accounts for 0.1% of the portfolio, ranked #119.

Allstate Corporation first reported a position in MDT in Q2 2013 and has held it in 46 quarters since. The position peaked at $14.2M in Q4 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Allstate Corporation held 107,175 shares of Medtronic worth $9.29M as of Q1 2026.
  • Allstate Corporation bought 10,853 Medtronic shares in Q1 2026, an estimated $1.04M.
  • Medtronic made up 0.1% of Allstate Corporation's portfolio in Q1 2026, its #119 holding.
  • Allstate Corporation first reported a position in Medtronic in Q2 2013 and has held it in 46 quarters since.
  • Allstate Corporation's Medtronic position peaked at $14.2M in Q4 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.